Teleman Dan Benjamin's Form 4 filing
Nasus Pharma Ltd (NSRX) · filed Jul 29, 2026
- Accession no.
- 0001493152-26-035218
- Filed
- Jul 29, 2026, 5:00 PM ET
- Rule 10b5-1 plan
- Not checked
This filing lists 0 non-derivative transactions and 0 derivative transactions.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Teleman Dan BenjaminCIK 0002122500 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.